Raymond James Financial Services Advisors, Inc. Uni Qure N.V. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Uni Qure N.V. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 11,916 shares of QURE stock, worth $690,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,916
Previous 10,286
15.85%
Holding current value
$690,174
Previous $46,000
26.09%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding QURE
# of Institutions
187Shares Held
51.8MCall Options Held
4.43MPut Options Held
1.27M-
Rtw Investments, LP New York, NY5.16MShares$299 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$231 Million4.79% of portfolio
-
Vestal Point Capital, LP New York, NY3.7MShares$214 Million2.72% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$210 Million0.92% of portfolio
-
Abrdn PLC2.75MShares$159 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $2.71B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...